Salvianolic acid B in vitro inhibited matrix metalloproteinases-1, -2, and -9 activities
Authors:
- Ping LiPLPing Li
- Qi-Fu HuangQHQi-Fu Huang
- Jing-Xia ZhaoJZJing-Xia Zhao
- Xin LiuXLXin Liu
- Miao-Ke DaiMDMiao-Ke Dai
- 15 February 2009
- journal article
- Published by Journal of Chinese Integrative Medicine Press in Journal of Chinese Integrative Medicine
- Vol. 7 (2) , 145-150
Abstract
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases, which as a group can degrade essentially all extracellular matrix components. The proteolytic property of the MMPs is important during wound healing to remove debris and facilitate cell migration. Targeting towards the decreased MMPs activities is a new treatment strategy for healing chronic wounds. Salvia miltiorrhiza is a popular Chinese herb that could promote chronic ulcers healing for topical use. Salvianolic acid B (Sal B) is the most abundant bioactive component in Salvia miltiorrhiza. The research was designed to explore the inhibitory effects of Sal B on MMP-1, MMP-2 and MMP-9 activities. Pure human interstitial collagenase (MMP-1) or gelatinase A (MMP-2) was activated by p-aminophenylmercuric acetate (APMA), and was incubated with Sal B for 1 h. The activities were observed by quenched fluorescent substrate. Gelatinase B (MMP-9) is rich in polymorphonuclear neutrophils (PMN), so the rat PMN was used as a source of MMP-9 for MMPs activity assays. In vitro MMP-9 from rats' PMN lysate was incubated with Sal B for 1 h, and its activity was tested by gelatin zymography. Sal B dose-dependently inhibited the human MMP-1 and MMP-2 activities in the range of 0.002 4 to 0.3 g/L, with 50% inhibiting concentration (IC(50)) of (0.090<0.015) g/L and (0.080<0.005) g/L respectively. In the range of 0.003 to 0.3 g/L, Sal B could inhibit the MMP-9 activity (P<0.01). The broad-spectrum inhibitory effects of Sal B on MMPs may reveal one of the mechanisms for the effects of Salvia miltiorrhiza on chronic wounds.Keywords
This publication has 18 references indexed in Scilit:
- Treatment of chronic skin ulcers with traditional Chinese medicine: a report of five casesJournal of Chinese Integrative Medicine, 2007
- The Impact of Differential Expression of Extracellular Matrix Metalloproteinase Inducer, Matrix Metalloproteinase-2, Tissue Inhibitor of Matrix Metalloproteinase-2 and PDGF-AA on the Chronicity of Venous Leg UlcersEuropean Journal of Vascular and Endovascular Surgery, 2006
- Targeting matrix metalloproteases to improve cutaneous wound healingExpert Opinion on Therapeutic Targets, 2006
- What Can Wound Fluids Tell Us About the Venous Ulcer Microenvironment?The International Journal of Lower Extremity Wounds, 2002
- Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patientsDiabetologia, 2002
- Wound Fluids from Human Pressure Ulcers Contain Elevated Matrix Metalloproteinase Levels and Activity Compared to Surgical Wound FluidsJournal of Investigative Dermatology, 1996
- Matrix Metalloproteinases, Gelatinase and Collagenase, in Chronic Leg UlcersJournal of Investigative Dermatology, 1996
- Growth factors and wound healing: Part II. Role in normal and chronic wound healingThe American Journal of Surgery, 1993
- Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9Journal of Investigative Dermatology, 1993
- Chronic Wounds: Pathophysiologic and Experimental ConsiderationsJournal of Investigative Dermatology, 1993